Synthesis and Anticancer Activities of 4-[(Halophenyl)‎diazenyl]phenol and 4-[(Halophenyl)‎diazenyl]phenyl Aspirinate Derivatives against Nasopharyngeal Cancer Cell Lines

Abstract EN

Aspirin and azo derivatives have been widely studied and have drawn considerable attention due to diverse biological activities.

In this study, a series of 4-[(halophenyl)diazenyl]phenyl aspirinate derivatives were synthesized from the reaction of aspirin with 4-[(halophenyl)diazenyl]phenol via esterification, in the presence of DCC/DMAP in DCM with overall yield of 45–54%.

4-[(Halophenyl)diazenyl]phenol was prepared prior to esterification from coupling reaction of aniline derivatives and phenol in basic solution.

All compounds were characterized using elemental analysis, FTIR, and 1H and 13C NMR spectroscopies.

All compounds were screened for their anticancer activities against nasopharyngeal cancer (NPC) HK-1 cell lines and the viability of cultured cells was determined by MTS [3-(4,5-dimethylthiazol-2-yl)-5-(3-carboxylmethoxylphenyl)-2-(4-sulfophenyl)-2H-tetrazolium]-based colorimetric assay.

4-[(E)-(Fluorophenyl)diazenyl]phenol showed the highest anticancer activity against NPC HK-1 cell lines compared to other synthesized compounds.

4-[(Halophenyl)diazenyl]phenyl aspirinate showed low cytotoxicity against NPC HK-1 cell lines compared to 4-[(halophenyl)diazenyl]phenol but better anticancer activity than aspirin alone.